Pulmonary necrosis resulting from DNA vaccination against tuberculosis. - Wikidata - wikimedia - TriplyDB

Pulmonary necrosis resulting from DNA vaccination against tuberculosis.

Pulmonary necrosis resulting from DNA vaccination against tuberculosis.

http://www.wikidata.org/entity/Q34854656

about

Tuberculosis vaccines: beyond bacille Calmette-Guerin Heat shock proteins: stimulators of innate and acquired immunity Ipr1 gene mediates innate immunity to tuberculosis.Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial Permutations of time and place in tuberculosis Protection against tuberculosis by a single intranasal administration of DNA-hsp65 vaccine complexed with cationic liposomes.Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in Mycobacterium tuberculosis-infected individuals.bioA mutant of Mycobacterium tuberculosis shows severe growth defect and imparts protection against tuberculosis in guinea pigs.Factors associated with severe granulomatous pneumonia in Mycobacterium tuberculosis-infected mice vaccinated therapeutically with hsp65 DNA.A booster vaccine expressing a latency-associated antigen augments BCG induced immunity and confers enhanced protection against tuberculosis.Pathological role of interleukin 17 in mice subjected to repeated BCG vaccination after infection with Mycobacterium tuberculosis.Use of specific rRNA oligonucleotide probes for microscopic detection of Mycobacterium tuberculosis in culture and tissue specimens.Protective effect of DNA vaccine during chemotherapy on reactivation and reinfection of Mycobacterium tuberculosis.On the use of DNA vaccines for the prophylaxis of mycobacterial diseases.Cell-mediated immune responses in tuberculosis.Pulmonary lymphatics are primary sites of Mycobacterium tuberculosis infection in guinea pigs infected by aerosol Next generation: tuberculosis vaccines that elicit protective CD8+ T cells Mycobacterium tuberculosis-specific CD8+ T cells and their role in immunity.Post-exposure vaccination against Mycobacterium tuberculosis.Tuberculosis: a problem with persistence.Rifapentine, moxifloxacin, or DNA vaccine improves treatment of latent tuberculosis in a mouse model.Developing an improved vaccine against tuberculosis.Tuberculosis vaccine development: research, regulatory and clinical strategies.Sequential chemoimmunotherapy of experimental visceral leishmaniasis using a single low dose of liposomal amphotericin B and a novel DNA vaccine candidate.The tuberculous granuloma: an unsuccessful host defence mechanism providing a safety shelter for the bacteria?Mixed-strain mycobacterium tuberculosis infections and the implications for tuberculosis treatment and control Tuberculosis vaccines: current status and future prospects.Translational mini-review series on vaccines: Development and evaluation of improved vaccines against tuberculosis.CBA/J mice generate protective immunity to soluble Ag85 but fail to respond efficiently to Ag85 during natural Mycobacterium tuberculosis infection.Tuberculosis subunit vaccines: from basic science to clinical testing.Immunotherapy of tuberculosis with Mycobacterium leprae Hsp65 as a DNA vaccine triggers cross-reactive antibodies against mammalian Hsp60 but not pathological autoimmunity.A single dose of a DNA vaccine encoding apa coencapsulated with 6,6'-trehalose dimycolate in microspheres confers long-term protection against tuberculosis in Mycobacterium bovis BCG-primed mice.Enhancement of the expression of HCV core gene does not enhance core-specific immune response in DNA immunization: advantages of the heterologous DNA prime, protein boost immunization regimen Lessons for tuberculosis vaccines from respiratory virus infection.The role of cytokines in the initiation, expansion, and control of cellular immunity to tuberculosis.Protection elicited by a double leucine and pantothenate auxotroph of Mycobacterium tuberculosis in guinea pigs.TB vaccines: current status and future perspectives.Antituberculous vaccine development: a perspective for the endemic world.Innate and Adaptive Cellular Immune Responses to Mycobacterium tuberculosis Infection.Adjunct immunotherapy with Ag85 complex proteins based subunit vaccine in a murine model of Mycobacterium tuberculosis infection.

P2860

Q22242669-82568E34-FB5B-4B19-9535-644D3D8FC57E Q26829100-3B63BA5A-2922-4F6B-83C1-05BCE56047AA Q28585986-4D1BCF32-A0E9-4476-83D4-9ADF8F399193 Q29620144-04F0CA2E-F7A2-479B-ABBF-358EB02142B3 Q30378562-3A9FED4A-72E6-4B2F-A9EF-F7C25C4E72E5 Q33353872-B0B33AA1-8B8B-4F9D-AAB3-81A2C41A9513 Q33807147-CDE1BC4A-89E5-4EDF-A83A-04ACF6673CCF Q33848397-731BE509-73C7-4A4D-B080-EC2C31E0B492 Q33946859-9E6CE832-501E-4CD7-BC98-3AB55CE6E3DE Q33999520-14D15DF3-211A-4A7B-AE42-09D08AE1FE26 Q34044493-B0686EC3-B76C-449F-A71B-837BA1F2706A Q34073449-D1A488F5-6952-48A2-A57D-A1A025123C5F Q34554776-AA1B081D-693A-450B-ADAB-5084987207EF Q34852418-9F9EAEAE-627A-42CF-8A05-41C8EC990032 Q34982062-3A4DCACD-1B2C-4189-98B7-2B3DCCB3418B Q35073776-8A4B3B8E-1C53-49DF-AB58-E94648164FEF Q35099708-7995EC10-7CE6-4436-B538-89F4DDA23FE6 Q35099713-CB16A876-E1A8-48D0-9E6D-CC30E34AA5D8 Q35101154-A6750A72-FF8D-4376-BD8D-54F52473A564 Q35701685-8FF78F2B-991C-4FEA-B73F-DEDBA35A7598 Q35754209-8D08EF06-0BE2-46AE-B02A-A400D9CF0A5D Q35791774-4097CB4B-5866-4B2A-894C-D5EE26652DAE Q35873788-B37ACAC6-1200-4538-B87D-C03219E7CC6C Q35960819-9AA1E69C-C9F6-4ECA-898A-BA5F572A1B59 Q36090400-70375E08-0B52-463E-8F05-6FE1369126BF Q36361918-3972D505-3B9F-40BF-B46D-E7D84B2F74A6 Q36458393-45FF64EE-DCE3-476C-8C01-5155A90DF24B Q36736465-D2FCF56A-6B5A-409A-9A87-F04DCE9F3E3B Q36811028-B6F943B6-B3B5-4BC8-9EF1-11553E362350 Q36960497-C59CD79E-BDBE-4DA5-8151-6196CA695A43 Q36977794-9A30BC53-ACEB-4C57-9215-3F6BAF1D329B Q37124690-C618183D-F2E7-410B-9D9F-95879F3227A5 Q37242521-6036BA88-D6A2-4524-873C-9DF6C8266A5D Q37290093-A714AB4C-62E3-4E18-A0C5-5E4A50E8E44F Q37374958-E0C21DFE-1748-4C26-9CA4-CF7463B76B87 Q37426754-9BE7FBD0-EFB6-4CA1-9DFA-DA73592773EB Q37435926-4EBD44A3-34CD-4BFC-914F-9A4E7884AAD4 Q37622900-C2AB1288-A1F0-47D9-9C7D-93166AF7B33F Q38549766-AA3B249A-0A3F-4ECE-B6EA-1B12248C523F Q40014676-BD3C4A16-4CDF-4DCB-9675-0334CF35431D

P2860

Pulmonary necrosis resulting from DNA vaccination against tuberculosis.

http://www.wikidata.org/entity/Q34854656

description

2003 nî lūn-bûn

@nan

2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Pulmonary necrosis resulting from DNA vaccination against tuberculosis.

@en

Pulmonary necrosis resulting from DNA vaccination against tuberculosis.

@nl

type

label

Pulmonary necrosis resulting from DNA vaccination against tuberculosis.

@en

Pulmonary necrosis resulting from DNA vaccination against tuberculosis.

@nl

prefLabel

Pulmonary necrosis resulting from DNA vaccination against tuberculosis.

@en

Pulmonary necrosis resulting from DNA vaccination against tuberculosis.

@nl

P1433

Q34854656-8E4A8F37-27BF-46D7-BF90-46EE2C7B9366

P1476

Q34854656-3023C9CB-772E-4524-9DAA-1DEBACB86160

P2093

Q34854656-39991F6A-0CD8-4B34-9433-B25703E837BA

Q34854656-489CB004-F880-4033-8E9E-AEB4E685E706

Q34854656-4B2A4193-0DF9-4EA9-A04B-4AB8B3E9BC38

Q34854656-C1504B68-DDCB-4C13-B8ED-034AEF6B308F

P2860

Q34854656-0D06B8AA-F49B-41E8-B12D-88E6F1DF6E2B

Q34854656-1CA6F8D7-7B7D-4808-8533-00417EFF6FD5

Q34854656-1CCA67F3-7715-43D3-81CE-9E433D28BCBA

Q34854656-29DC1C50-C6A6-4B50-8201-8FE5F857917C

Q34854656-33AA8683-80E6-4B89-B58A-8C6F1C440DF9

Q34854656-34DDA025-9076-41E0-9E46-86E6EA46FDC5

Q34854656-36AF2D11-376B-4C34-B3E8-B2A74E2F69AD

Q34854656-3DEFB7EA-1E20-4E2B-A3DB-5DBAB519FEA8

Q34854656-55325A7B-5742-4600-8D92-C9E5918FCA90

Q34854656-60B0BAFD-2FC3-4827-BBD1-78D3DA9B51DD

P304

Q34854656-3044D973-112E-41E7-8AFF-7E316B977813

P31

Q34854656-F659B770-6CCB-43A8-BC5E-FD93312E643D

P356

Q34854656-A706701C-E1D6-4A56-9E92-5DE40A9FB861

P407

Q34854656-F3F10659-52A2-4FFA-BFE3-F14FDC66F915

P433

Q34854656-19C9F779-B6FC-4A67-92CB-1B0A3F068B36

P478

Q34854656-78973C95-1B77-4FEE-9C9D-9AC1508C104B

P50

Q34854656-8D82A7C5-0E47-47F4-B571-7196F472FACC

Q34854656-CB868840-720E-4CF3-867A-573DFD453756

P577

Q34854656-83AC639B-36ED-4659-B530-DBCD23DF793E

P5875

Q34854656-EB390ADA-CD65-4BFE-9273-6E1A03FF44C8

P698

Q34854656-327C4B09-C6FB-4BD1-973A-ACFBF785C7A9

P921

Q34854656-78449DB2-E437-4173-B90A-D1F6A3697673

P932

Q34854656-E963A5EB-F7A2-4968-88D5-B46ED238AC69

P356

IAI.71.4.2192-2198.2003

P1433

Infection and Immunity

P1476

Pulmonary necrosis resulting from DNA vaccination against tuberculosis.

@en

P2093

Ian M Orme

http://www.w3.org/2001/XMLSchema#string

Jennifer L Taylor

http://www.w3.org/2001/XMLSchema#string

Oliver C Turner

http://www.w3.org/2001/XMLSchema#string

Randall J Basaraba

http://www.w3.org/2001/XMLSchema#string

P2860

Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project

Metronidazole therapy in mice infected with tuberculosis

Transient loss of resistance to pulmonary tuberculosis in p47(phox-/-) mice

Immunology of tuberculosis

Evaluation of new vaccines in the mouse and guinea pig model of tuberculosis

Beyond BCG: the potential for a more effective TB vaccine.

Reactivation of latent tuberculosis: variations on the Cornell murine model

Effective preexposure tuberculosis vaccines fail to protect when they are given in an immunotherapeutic mode.

Lack of protection in mice and necrotizing bronchointerstitial pneumonia with bronchiolitis in guinea pigs immunized with vaccines directed against the hsp60 molecule of Mycobacterium tuberculosis

Mycobacterial antigens exacerbate disease manifestations in Mycobacterium tuberculosis-infected mice.

P304

2192-2198

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/IAI.71.4.2192-2198.2003

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

71

http://www.w3.org/2001/XMLSchema#string

P50

P577

2003-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7843898

http://www.w3.org/2001/XMLSchema#string

P698

12654841

http://www.w3.org/2001/XMLSchema#string

P921

Akafuba bulwadde

P932

152079

http://www.w3.org/2001/XMLSchema#string